Evaluating diagnostic markers for joint infections in hip and knee surgeries
Official title: Diagnostic Accuracy and Cost-effectiveness Analysis of Serum and Synovial Fluid Markers for the Diagnosis of Periprosthetic Hip and Knee Joint Infections
Run by Istituto Ortopedico Rizzoli · NCT04858217 · Data updated 2026-11-12
This study is testing if certain blood and joint fluid markers can help doctors quickly and accurately diagnose joint infections in patients having hip or knee revision surgeries.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 270 (estimated) |
| Sponsor | Istituto Ortopedico Rizzoli Academic / other |
| Locations | 1 site (Bologna) |
| Status | Recruiting |
| Started | February 1, 2022 |
| Main results expected | June 17, 2025 |
| Study ends | March 31, 2026 |
| Registry record updated | September 22, 2025 |
| Trial ID | NCT04858217 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients requiring hip or knee replacement surgery due to late joint prosthesis infection or non-infectious causes, with a history of at least 90 days since their initial surgery.
✕Probably not a fit
Patients with early joint prosthesis infections or those with infections in joints other than the hip or knee may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to assess the diagnostic accuracy and cost-effectiveness of serum and synovial markers in identifying periprosthetic joint infections (PJI) in patients undergoing revision surgery for hip or knee replacements. By analyzing the combination of these biomarkers, the research seeks to improve the speed and accuracy of PJI diagnosis, which is crucial for determining the appropriate surgical strategy. The study will involve patients hospitalized for revision surgery, utilizing existing clinical data and laboratory examinations to evaluate the effectiveness of these markers.
Why it matters
Potential benefit: If successful, this study could lead to faster and more accurate diagnoses of joint infections, improving treatment outcomes for patients.
How similar studies have gone: Other studies have shown promise in using biomarkers for diagnosing infections, but this specific combination of serum and synovial markers is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients requiring hip or knee replacement surgery: i) for 'late' joint prosthesis infection, present for at least 90 days from the date of the arthroplasty (first surgical phase); II) for non-infectious causes (mobilization, wear, instability, misalignment, adverse reactions to local tissues or other aseptic causes), also present for at least 90 days, and which have not had other re-operations on the same joint, and which will be a one-step review; * Previous clinical data and laboratory and radiological examinations available. Exclusion Criteria: * Patients affected by 'early' joint prosthesis infection, with clinical symptom latency of less than 90 days (in this specific subset of patients there is in fact still considerable heterogeneity and little consensus about the diagnostic levels of white blood cell count and percentage of neutrophils). * Patients suffering from joint prosthesis infection involving joints other than the hip or knee. * Severe cognitive impairment or psychiatric disorders; * Pregnant women.
Where it's running
-
IRCCS Istituto Ortopedico Rizzoli
Bologna, Italy Recruiting
Study contacts
- Principal investigator: Gianluca Giavaresi, MD — Istituto Ortopedico Rizzoli
- Study coordinator: Gianluca Giavaresi, MD
- Email: gianluca.giavaresi@ior.it
- Phone: +39 3774548728
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How knee and hip joint replacements are doing over time
This observational study follows adults who have knee or hip replacements to see how their outcomes look over time after the surgery.
-
Population pharmacokinetics of rifampicin in staphylococcal osteoarticular infections
This study tests how rifampicin behaves in the body of adults with staphylococcal osteoarticular infections when given with levofloxacin or ciprofloxacin, to see how drug exposure relates to tolerance and outcomes.
-
Reducing bacterial contamination during primary shoulder replacement
This trial tests whether putting Prontosan antimicrobial gel on the dermal layer after the skin is cut can lower Cutibacterium acnes growth in men having primary shoulder replacement.
-
Methylene blue dye to measure how much irrigation clears contamination during knee replacement procedures
We will test whether putting methylene blue dye into the knee during replacement or DAIR procedures can show how much irrigation is needed to wash out contaminants.
-
PLG0206 irrigation to prevent repeat knee replacement infections after DAIR
This will test if washing the knee with PLG0206 during a DAIR procedure can lower the chance that a prosthetic knee infection comes back in adults who had a knee replacement.
-
Prosthetic joint infection patterns in critically ill patients who died
This project looks at health records of adults who died in intensive care with a hip, knee, or shoulder prosthetic joint infection from 2018–2022 to see common care paths and outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.